Veterinary Nutraceutics, Pharmaceutics and Vaccine

Preview this chapter:

Veterinary Nutraceutics, Pharmaceutics and Vaccine, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815036664/chapter-12-1.gif

Animals have been utilized extensively as part and parcel of pharmaceutical and vaccine development. Many studies from animal models for human diseases have re-affirmed inventions in the field of medicine. Animal nutraceuticals of biological origin have marked exceptional promise by enhancing the production and performance of commercial animals. Transgenic animals have helped transform laboratory-scale developments into clinical applications. The nutraceutical potential of animal products is a fascinating area of research with considerable anti-microbial, anti-cancer, antiinflammatory, anti-diabetic and neuroprotective functions. Vaccines in veterinary sciences have been revolutionized based on the efficacy demonstrated by animal models. Vaccines are being routinely used against bacteria, viruses and some parasites at commercial levels. Third-generation vaccines that were thought to be very expensive in the last century are now being commercially produced and marketed worldwide for animal health. Most recently, many avenues have opened that encourage the use of biologically derived pharmaceuticals and vaccine products. This chapter deals with a very comprehensive contrast of history and recent trends in veterinary pharmaceuticals and vaccines. It concludes that more research focus is required to come up with more efficient treatment and prophylactic approaches amidst mutating pathogens of concern.